Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Costantini E et al. | 2022 | - | magnetic field, low frequency, 50/60 Hz | - |
Cridland NA et al. | 1996 | intact cell/cell culture, HF-19 cells (normal human fibroblasts derived from fetal female lung) | magnetic field, 50/60 Hz, power transmission line | 20 µT–20 mT |
Dees C et al. | 1996 | intact cell/cell culture, MCF-7 and T-47D cell lines (human breast cancer cell lines) | magnetic field, 50/60 Hz, co-exposure | 1.2–900 µT |
Del Re B et al. | 2004 | bacterium, <i>Escherichia coli</i>/Lac Z<sup>-</sup> strain (transformed with a plasmid containing a Tn10 derivative element expressing beta-galactosidase only after transposition)) | magnetic field, low frequency, 50/60 Hz | 0.05–1 mT |
Delle Monache S et al. | 2008 | intact cell/cell culture, human vein endothelial cells (HUVEC) | magnetic field, low frequency, 50/60 Hz | 1 mT |
Delle Monache S et al. | 2013 | intact cell/cell culture, human umbilical vein endothelial cells (HUVEC) and mouse pancreatic endothelial cell line (MS-1) | magnetic field, low frequency, 50/60 Hz | 1–2 mT |
Denaro V et al. | 2011 | intact cell/cell culture | low frequency, signals/pulses, 50/60 Hz, magnetic field | 0.4 mT |
Destefanis M et al. | 2015 | intact cell/cell culture, SKBR3 (human breast cancer cells), GTL16 (human gastric cancer cells), HT29 (human colon cancer cells), A375P (human melanoma cells) | magnetic field, 50/60 Hz | 12 µT |
Ding GR et al. | 2001 | intact cell/cell culture, MCF-7 (human breast cancer cell line) | magnetic field, 50/60 Hz, co-exposure | 5 mT |
Domínguez G et al. | 2021 | intact cell/cell culture, MDCK cells (Madin-Darby canine kidney cell line) | magnetic field, 50/60 Hz | 1–5 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.